Go Pro

Certara (CERT) Competitors

Certara logo
$6.98 +0.05 (+0.71%)
As of 03:40 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CERT vs. BILL, DOCS, CLBT, BOX, and XNDU

Should you buy Certara stock or one of its competitors? MarketBeat compares Certara with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Certara include BILL (BILL), Doximity (DOCS), Cellebrite DI (CLBT), BOX (BOX), and Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU). These companies are all part of the "computer software" industry.

How does Certara compare to BILL?

Certara (NASDAQ:CERT) and BILL (NYSE:BILL) are both computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, BILL had 6 more articles in the media than Certara. MarketBeat recorded 11 mentions for BILL and 5 mentions for Certara. Certara's average media sentiment score of 0.17 beat BILL's score of 0.16 indicating that Certara is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BILL
1 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

BILL has a net margin of 0.01% compared to Certara's net margin of -3.60%. Certara's return on equity of 3.52% beat BILL's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-3.60% 3.52% 2.42%
BILL 0.01%2.40%0.91%

Certara currently has a consensus price target of $8.85, indicating a potential upside of 26.81%. BILL has a consensus price target of $55.50, indicating a potential upside of 21.65%. Given Certara's higher possible upside, analysts plainly believe Certara is more favorable than BILL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
BILL
1 Sell rating(s)
9 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.57

Certara has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, BILL has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market.

74.0% of Certara shares are owned by institutional investors. Comparatively, 98.0% of BILL shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 13.2% of BILL shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

BILL has higher revenue and earnings than Certara. BILL is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$418.84M2.59-$1.60M-$0.10N/A
BILL$1.46B3.11$23.80M-$0.01N/A

Summary

BILL beats Certara on 10 of the 16 factors compared between the two stocks.

How does Certara compare to Doximity?

Certara (NASDAQ:CERT) and Doximity (NYSE:DOCS) are both computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

In the previous week, Doximity had 1 more articles in the media than Certara. MarketBeat recorded 6 mentions for Doximity and 5 mentions for Certara. Doximity's average media sentiment score of 0.69 beat Certara's score of 0.17 indicating that Doximity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Doximity
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Certara presently has a consensus price target of $8.85, indicating a potential upside of 26.81%. Doximity has a consensus price target of $29.33, indicating a potential upside of 35.83%. Given Doximity's higher probable upside, analysts plainly believe Doximity is more favorable than Certara.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
Doximity
3 Sell rating(s)
13 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.29

Doximity has a net margin of 30.40% compared to Certara's net margin of -3.60%. Doximity's return on equity of 20.40% beat Certara's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-3.60% 3.52% 2.42%
Doximity 30.40%20.40%17.43%

Certara has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Doximity has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$418.84M2.59-$1.60M-$0.10N/A
Doximity$644.86M6.12$196.05M$0.9921.81

74.0% of Certara shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 31.3% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Doximity beats Certara on 15 of the 17 factors compared between the two stocks.

How does Certara compare to Cellebrite DI?

Certara (NASDAQ:CERT) and Cellebrite DI (NASDAQ:CLBT) are both computer software companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

In the previous week, Certara had 3 more articles in the media than Cellebrite DI. MarketBeat recorded 5 mentions for Certara and 2 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 1.48 beat Certara's score of 0.17 indicating that Cellebrite DI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cellebrite DI
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

74.0% of Certara shares are owned by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 5.7% of Cellebrite DI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Certara currently has a consensus target price of $8.85, suggesting a potential upside of 26.81%. Cellebrite DI has a consensus target price of $21.40, suggesting a potential upside of 38.56%. Given Cellebrite DI's stronger consensus rating and higher probable upside, analysts clearly believe Cellebrite DI is more favorable than Certara.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
Cellebrite DI
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Cellebrite DI has a net margin of 14.48% compared to Certara's net margin of -3.60%. Cellebrite DI's return on equity of 18.38% beat Certara's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-3.60% 3.52% 2.42%
Cellebrite DI 14.48%18.38%9.68%

Certara has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Cellebrite DI has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$418.84M2.59-$1.60M-$0.10N/A
Cellebrite DI$475.67M8.10$78.33M$0.2855.16

Summary

Cellebrite DI beats Certara on 12 of the 16 factors compared between the two stocks.

How does Certara compare to BOX?

Certara (NASDAQ:CERT) and BOX (NYSE:BOX) are both computer software companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

74.0% of Certara shares are owned by institutional investors. Comparatively, 86.7% of BOX shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Comparatively, 4.0% of BOX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Certara currently has a consensus target price of $8.85, suggesting a potential upside of 26.81%. BOX has a consensus target price of $35.33, suggesting a potential upside of 14.41%. Given Certara's stronger consensus rating and higher probable upside, equities research analysts plainly believe Certara is more favorable than BOX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46
BOX
1 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.22

In the previous week, Certara had 3 more articles in the media than BOX. MarketBeat recorded 5 mentions for Certara and 2 mentions for BOX. BOX's average media sentiment score of 1.33 beat Certara's score of 0.17 indicating that BOX is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Certara
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BOX
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Certara has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market. Comparatively, BOX has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

BOX has a net margin of 10.35% compared to Certara's net margin of -3.60%. Certara's return on equity of 3.52% beat BOX's return on equity.

Company Net Margins Return on Equity Return on Assets
Certara-3.60% 3.52% 2.42%
BOX 10.35%-24.19%4.66%

BOX has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than BOX, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Certara$418.84M2.59-$1.60M-$0.10N/A
BOX$1.18B3.63$115.38M$0.6547.51

Summary

BOX beats Certara on 10 of the 17 factors compared between the two stocks.

How does Certara compare to Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares?

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (NASDAQ:XNDU) and Certara (NASDAQ:CERT) are both computer software companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares has a beta of 15, indicating that its stock price is 1,400% more volatile than the broader market. Comparatively, Certara has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares has higher earnings, but lower revenue than Certara. Certara is trading at a lower price-to-earnings ratio than Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xanadu Quantum Technologies Limited Class B Subordinate Voting SharesN/AN/AN/A-$0.28N/A
Certara$418.84M2.59-$1.60M-$0.10N/A

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Certara had 2 more articles in the media than Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares. MarketBeat recorded 5 mentions for Certara and 3 mentions for Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares. Certara's average media sentiment score of 0.17 beat Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares' score of 0.00 indicating that Certara is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Certara
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares currently has a consensus price target of $44.00, suggesting a potential upside of 304.41%. Certara has a consensus price target of $8.85, suggesting a potential upside of 26.81%. Given Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares' higher probable upside, equities analysts clearly believe Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares is more favorable than Certara.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Certara
1 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.46

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares has a net margin of 0.00% compared to Certara's net margin of -3.60%. Certara's return on equity of 3.52% beat Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares' return on equity.

Company Net Margins Return on Equity Return on Assets
Xanadu Quantum Technologies Limited Class B Subordinate Voting SharesN/A N/A N/A
Certara -3.60%3.52%2.42%

Summary

Certara beats Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares on 11 of the 15 factors compared between the two stocks.

Get Certara News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CERT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CERT vs. The Competition

MetricCertaraMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.09B$3.64B$6.80B$12.31B
Dividend YieldN/A2.17%2.67%9.36%
P/E Ratio-69.9520.8427.1624.03
Price / Sales2.59302.97573.71113.02
Price / Cash9.1660.3129.0548.09
Price / Book1.057.9310.676.16
Net Income-$1.60M$23.81M$3.59B$331.63M
7 Day Performance2.78%-1.69%-1.46%-1.53%
1 Month Performance25.97%2.24%1.20%-1.24%
1 Year Performance-30.90%43.54%24.36%17.49%

Certara Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CERT
Certara
3.4683 of 5 stars
$6.98
+0.7%
$8.85
+26.8%
-31.4%$1.09B$418.84MN/A1,576
BILL
BILL
3.6935 of 5 stars
$42.94
+3.8%
$55.19
+28.5%
-2.3%$4.12B$1.46BN/A2,364
DOCS
Doximity
3.7088 of 5 stars
$22.31
+2.5%
$29.33
+31.5%
N/A$3.98B$644.86M22.53890
CLBT
Cellebrite DI
4.439 of 5 stars
$16.13
+1.2%
$21.40
+32.7%
+7.4%$3.98B$475.67M57.611,285
BOX
BOX
3.547 of 5 stars
$29.38
+2.6%
$35.33
+20.3%
-5.7%$3.97B$1.18B45.202,912

Related Companies and Tools


This page (NASDAQ:CERT) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners